Understanding the role of estrogen on cognition and dementia

  • Mary Sano
Conference paper


There is growing evidence that post menopausal use of estrogen may have a beneficial effect on cognition and may reduce the risk of dementia. In a vast majority of studies, the use of estrogen replacement in the postmenopausal period was associated with a reduced risk of dementia. Meta-analyses of both retrospective case controlled and prospective studies indicate a 30% reduction in the risk of dementia, with larger effect sizes (50% reduction) reported in the latter. Some, but not all, large epidemiological studies indicate that estrogen use is associated with better performance on both verbal and visual memory testing in later life. However, studies of the effect of estrogen on patients with Alzheimer’s disease are less convincing with minimal effects reported in open trials and following brief exposure. Biological mechanisms, which could be responsible for some of these effects, include activation of the cholinergic system, anti-oxidant action, neurotrophic stimulation and anti-amyloidogenic properties. Beneficial effects of estrogen in primary prevention but not secondary prevention of heart disease indicates that the ability to observe beneficial effects may depend on the point at which intervention occurs. Ongoing double-blind randomized clinical trial to determine if estrogen is a safe and effective treatment for the prevention of memory loss and Alzheimer’s disease will be described. Future work will undoubtedly include the identification of specific estrogenic receptors in the central nervous system that can be selectively activated without adverse involvement of other biologic systems.


Post Menopausal Woman Basal Forebrain Memory Loss Estrogen Replacement Therapy Postmenopausal Period 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR (1999) Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 24 (6): 657 – 677PubMedCrossRefGoogle Scholar
  2. Behl C, Widmann M, Trapp T, Holsboer F (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Comm 216(2): 473–482Google Scholar
  3. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia- Alzheimer’s type. Psychoneuroendocrinology 11: 337 – 345PubMedCrossRefGoogle Scholar
  4. Funk JL, Mortel KF, Meyer JS (1991) Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 2: 268 – 272Google Scholar
  5. Henderson VW, Paganini-Hill A, Miller BL, et al (2000) Estrogen for Alzheimer’s disease in women. Randomized, double-blind, placebo-controlled trial. Neurology 54: 295PubMedGoogle Scholar
  6. Honjo H, Ogino Y, Naitoh K, Urabe M, Kitawaki J, Yasuda J, Yamamoto T, Ishihara S, Okada H, Yonezawa T, Hayashi K, Nambara T (1989) In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer’s type). J Steroid Bioche 34: 521 – 525CrossRefGoogle Scholar
  7. Jacobs DM, Tang M-X, Stern Y, Sano M, Marder K, Bell KL, Schofield P, Dooneief G, Gurland B, Mayeux R (1998) Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50: 368 – 373PubMedGoogle Scholar
  8. Kawas C, Resnick S, Morrison A, et al (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: The Baltimore Longitudinal Study of Aging. Neurology 48: 1517 – 1521PubMedGoogle Scholar
  9. McEwan BS, Alves SE, Bulloch K, Weiland NG (1997) Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48 [Suppl 7]: S8 – S15Google Scholar
  10. Mulnard R, Cotman CW, Kawas C, et al (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer’s disease: A 1-year randomized controlled trial. JAMA 283 (8): 1007 – 1015PubMedCrossRefGoogle Scholar
  11. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaio Y, Hagino N (1994) Evaluation of estrogen in female patients with dementia of the Alzheimer type. Endocr J 41: 361 – 371PubMedCrossRefGoogle Scholar
  12. Phillips SM, Sherwin BB (1992) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17: 485 – 495PubMedCrossRefGoogle Scholar
  13. Relkin N, Orazem J, McRae T (1999) The effect of concomitant donepezil and perfor¬mance of women with Alzheimer’s disease. Neurology 53 [Suppl 2]: A397 Resnick SM, Metter EJ, Zonderman AB (1997) Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect? Neurology 49 (6): 1491 – 1497Google Scholar
  14. Schneider LS, Farlow MR, Henderson VW, Pogoda JM (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer’s disease. Neurology 46: 580 – 584Google Scholar
  15. Shaywitz SE, Shaywitz BA, Pugh KR, et al (1997) Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281 (13): 1197 – 1202Google Scholar
  16. Tang M-X, Jacobs D, Stern Y, et al (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348: 429 – 432PubMedCrossRefGoogle Scholar
  17. Toran-Allerand CD, Miranda RC, Bentham WD, et al (1992) Estrogen receptors colocalize with low affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89: 4668 – 4672PubMedCrossRefGoogle Scholar
  18. Xu H, Sweeney D, Wang R, et al (1997) Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Aca Sci USA 94: 3748 – 3752CrossRefGoogle Scholar
  19. Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279: 688 – 695PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2000

Authors and Affiliations

  • Mary Sano
    • 1
  1. 1.Department of Neurology, Sergievsky Center and Taub Institute for Alzheimer’s Disease ResearchColumbia University College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations